S&P 500   5,057.00 (+1.51%)
DOW   38,866.42 (+0.66%)
QQQ   435.71 (+2.37%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,057.00 (+1.51%)
DOW   38,866.42 (+0.66%)
QQQ   435.71 (+2.37%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,057.00 (+1.51%)
DOW   38,866.42 (+0.66%)
QQQ   435.71 (+2.37%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,057.00 (+1.51%)
DOW   38,866.42 (+0.66%)
QQQ   435.71 (+2.37%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)

Edgewise Therapeutics (EWTX) Short Interest Ratio & Short Volume

$17.57
+0.07 (+0.40%)
(As of 10:40 AM ET)

Edgewise Therapeutics Short Interest Data

Current Short Volume
5,400,000 shares
Previous Short Volume
8,170,000 shares
Change Vs. Previous Month
-33.90%
Dollar Volume Sold Short
$96.28 million
Short Interest Ratio / Days to Cover
6.3
Last Record Date
January 31, 2024
Outstanding Shares
63,460,000 shares
Float Size
47,060,000 shares
Short Percent of Float
11.47%
Today's Trading Volume
82,760 shares
Average Trading Volume
1,151,204 shares
Today's Volume Vs. Average
7%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Edgewise Therapeutics ?

Sign up to receive the latest short interest report for Edgewise Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EWTX Short Interest Over Time

EWTX Days to Cover Over Time

EWTX Percentage of Float Shorted Over Time


Edgewise Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20245,400,000 shares $96.28 million -33.9%11.5%6.3 $17.83
1/15/20248,170,000 shares $81.70 million -12.5%22.7%10.8 $10.00
12/31/20239,340,000 shares $102.18 million +9.9%25.9%20.1 $10.94
12/15/20238,500,000 shares $61.97 million +20.9%23.7%22.6 $7.29
11/30/20237,030,000 shares $42.74 million +11.1%19.6%24.7 $6.08
11/15/20236,330,000 shares $41.52 million +5.3%17.7%34.2 $6.56
10/31/20236,010,000 shares $38.46 million +4.5%17.0%35.9 $6.40
10/15/20235,750,000 shares $38.58 million +1.6%16.3%36.2 $6.71
9/30/20235,660,000 shares $32.43 million +2.2%16.1%33.2 $5.73
9/15/20235,540,000 shares $35.57 million +1.7%15.7%28.2 $6.42
8/31/20235,450,000 shares $34.06 million +1.1%13.9%26.9 $6.25
8/15/20235,390,000 shares $39.35 million -1.3%13.8%24.5 $7.30
7/31/20235,460,000 shares $39.80 million -12.1%13.7%24.8 $7.29
7/15/20236,210,000 shares $44.84 million +11.7%15.6%27.4 $7.22
6/30/20235,560,000 shares $43.09 million +3.5%14.0%26.4 $7.75
6/15/20235,370,000 shares $46.83 million +12.6%13.5%25 $8.72
5/31/20234,770,000 shares $48.27 million +5.8%12.0%25.3 $10.12
5/15/20234,510,000 shares $40.68 million +1.8%11.3%25.8 $9.02
4/30/20234,430,000 shares $38.85 million +6.2%11.0%25.6 $8.77
4/15/20234,170,000 shares $24.23 million +4.5%10.3%26.5 $5.81
3/31/20233,990,000 shares $26.61 million +6.1%9.9%25.1 $6.67
3/15/20233,760,000 shares $28.76 million -2.1%9.3%25.4 $7.65
2/28/20233,840,000 shares $36.79 million +1.6%9.5%22.4 $9.58
2/15/20233,780,000 shares $37.76 million -2.3%9.3%21.3 $9.99
1/31/20233,870,000 shares $39.59 million +29.9%9.6%21.5 $10.23
1/15/20232,980,000 shares $32.93 million -25.7%7.4%15.8 $11.05
12/30/20224,010,000 shares $35.85 million +38.8%10.0%20 $8.94
12/15/20222,890,000 shares $22.46 million -16.2%7.2%13.3 $7.77
11/30/20223,450,000 shares $30.88 million -3.1%8.6%11.8 $8.95
11/15/20223,560,000 shares $37.38 million -1.1%8.9%12 $10.50
10/31/20223,600,000 shares $34.24 million +8.4%8.9%12.1 $9.51
10/15/20223,320,000 shares $34.59 million +19.0%10.4%10.9 $10.42
9/30/20222,790,000 shares $27.45 million +5.3%10.2%9.2 $9.84
9/15/20222,650,000 shares $24.19 million -12.3%9.7%8.3 $9.13
8/31/20223,020,000 shares $30.44 million -17.0%10.8%12.3 $10.08
8/15/20223,640,000 shares $39.17 million +3.7%13.1%14.7 $10.76
7/31/20223,510,000 shares $33.94 million +3.2%12.5%13.5 $9.67
7/15/20223,400,000 shares $34.54 million +9.0%12.1%13.3 $10.16
6/30/20223,120,000 shares $24.84 million -3.1%11.1%12.6 $7.96
6/15/20223,220,000 shares $19.90 million +1.6%11.5%13.2 $6.18













EWTX Short Interest - Frequently Asked Questions

What is Edgewise Therapeutics' current short interest?

Short interest is the volume of Edgewise Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 5,400,000 shares of EWTX short. 11.47% of Edgewise Therapeutics' shares are currently sold short. Learn More on Edgewise Therapeutics' current short interest.

What is a good short interest ratio for Edgewise Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EWTX shares currently have a short interest ratio of 6.0. Learn More on Edgewise Therapeutics's short interest ratio.

Which institutional investors are shorting Edgewise Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edgewise Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Edgewise Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.47% of Edgewise Therapeutics' floating shares are currently sold short.

Is Edgewise Therapeutics' short interest increasing or decreasing?

Edgewise Therapeutics saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 5,400,000 shares, a decrease of 33.9% from the previous total of 8,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Edgewise Therapeutics' float size?

Edgewise Therapeutics currently has issued a total of 63,460,000 shares. Some of Edgewise Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edgewise Therapeutics currently has a public float of 47,060,000 shares.

How does Edgewise Therapeutics' short interest compare to its competitors?

11.47% of Edgewise Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edgewise Therapeutics: Avadel Pharmaceuticals plc (9.44%), MacroGenics, Inc. (14.23%), Geron Co. (7.49%), Centessa Pharmaceuticals plc (1.90%), ANI Pharmaceuticals, Inc. (1.18%), Avidity Biosciences, Inc. (10.31%), Tango Therapeutics, Inc. (20.63%), Akero Therapeutics, Inc. (13.93%), Innoviva, Inc. (19.24%), Amylyx Pharmaceuticals, Inc. (10.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Edgewise Therapeutics stock?

Short selling EWTX is an investing strategy that aims to generate trading profit from Edgewise Therapeutics as its price is falling. EWTX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Edgewise Therapeutics?

A short squeeze for Edgewise Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EWTX, which in turn drives the price of the stock up even further.

How often is Edgewise Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EWTX, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:EWTX) was last updated on 2/22/2024 by MarketBeat.com Staff